{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:56:55Z","timestamp":1787014615128,"version":"build-2736575974"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T00:00:00Z","timestamp":1234310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract\u2002<\/jats:bold>\n                    Acute studies suggested a therapeutic benefit for fundus\u2010relaxing drugs in functional dyspepsia (FD) with visceral hypersensitivity (VH) to gastric distention or impaired accommodation (IA), but long\u2010term studies are lacking. R\u2010137696 is a serotonin\u20101A (5\u2010HT\n                    <jats:sub>1A<\/jats:sub>\n                    ) receptor agonist which relaxes the proximal stomach in man. Our aim was to investigate the influence of R\u2010137696 on symptoms in FD with VH or IA. Randomized, double\u2010blind, placebo\u2010controlled, parallel group study of 4\u2003weeks R\u2010137696 2\u2003mg t.i.d. in FD with VH or IA. Symptoms were assessed using the patient assessment of upper gastrointestinal symptom severity index (PAGI\u2010SYM) total score and individual symptom subscales. Barostat studies were performed before and after 4\u2003weeks of treatment. Fifty\u2010three patients (33\u2003VH and 20\u2003IA), 18 men, mean age 40\u2003\u00b1\u200313\u2003years were recruited. Twenty\u2010four received placebo and 29 received R\u2010137696. In VH patients, both placebo and R\u2010137696 improved total symptom scores, with a tendency for superiority of placebo (\u22121.12\n                    <jats:italic>vs<\/jats:italic>\n                    \u22120.51,\n                    <jats:italic>P<\/jats:italic>\n                    \u2003=\u20030.07). Placebo was superior for the subscales of early satiety, bloating, fullness and discomfort (all\n                    <jats:italic>P<\/jats:italic>\n                    \u2003&lt;\u20030.05). In IA, both placebo and R\u2010137696 had no significant influence on total or individual symptom scores (\u22120.08 and \u22120.27). In VH, both placebo and R\u2010137696 increased the discomfort volume, without a statistical difference between both arms (+120 and +164\u2003mL). In IA, both placebo and R\u2010137696 enhanced accommodation, without a statistical difference between both (+77 and +159\u2003mL). Adverse events were similar for drug and placebo. A 4\u2010week administration of the fundus\u2010relaxing 5\u2010HT\n                    <jats:sub>1A<\/jats:sub>\n                    agonist R\u2010137696 failed to significantly improve symptoms, VH or gastric accommodation compared to placebo.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2982.2008.01260.x","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T21:04:25Z","timestamp":1234386265000},"page":"619","source":"Crossref","is-referenced-by-count":44,"title":["A placebo\u2010controlled trial of the 5\u2010HT\n                    <sub>1A<\/sub>\n                    agonist R\u2010137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia"],"prefix":"10.1111","volume":"21","author":[{"given":"J.","family":"Tack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Van Den Elzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Wajs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Van Nueten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Boeckxstaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,20]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/gut.45.2008.ii37","article-title":"Functional gastroduodenal disorders","volume":"45","author":"Talley NJ","year":"1999","journal-title":"Gut"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.05.030"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01281.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07389.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70012-5"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.27180"},{"key":"e_1_2_5_8_2","first-page":"2169","article-title":"Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms","volume":"98","author":"Simren M","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00359.x"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.07.005"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2006.00812.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70179-4"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.4.468"},{"key":"e_1_2_5_14_2","first-page":"A325","article-title":"A placebo\u2010controlled trial of buspirone, a fundus relaxing drug in functional dyspepsia: effect on symptoms and gastric sensory motor function (abstr)","volume":"116","author":"Tack J","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90057-8"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.49.2.203"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)00287-7"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05421.x"},{"issue":"2","key":"e_1_2_5_19_2","first-page":"G373","article-title":"Role of nitric oxide in fasting gastric fundus tone and in 5\u2010HT1 receptor\u2010mediated relaxation of gastric fundus","volume":"276","author":"Coulie B","year":"1999","journal-title":"Am J Physiol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00280.2002"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2004.03.054"},{"issue":"4","key":"e_1_2_5_22_2","first-page":"G902","article-title":"Sumatriptan, a selective 5\u2010HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans","volume":"272","author":"Coulie B","year":"1997","journal-title":"Am J Physiol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00419.2003"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-3565(04)00348-9"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00781.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03520.x"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01090.x"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702723"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00266.2002"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02845.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.11.059"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-006-1847-5"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2008.01260.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2982.2008.01260.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T02:05:21Z","timestamp":1695953121000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2008.01260.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,20]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1365-2982.2008.01260.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2008.01260.x","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,20]]}}}